| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ptc Therapeutics, Inc. (PTCT) has 18 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. PTCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 394.1K | $27.67M | - | |
| Dir | 163.3K | $11.46M | - | |
| CFO | 90.3K | $6.34M | - | |
| Other | 80.1K | $5.63M | - | |
| VP | 79.1K | $5.55M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2025 | Jacobson Allan Steven51 | Director | Sell | 1,667 | $50.15 | $83,600.05 | -8.7% | +73.2% | - | |
| Aug 15, 2025 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 2,813 | $48.58 | $136,655.54 | -2.6% | +53.5% | - | |
| Aug 5, 2025 | Klein Matthew B.54 | Chief Executive Officer | Sell | 10,739 | $51.74 | $555,635.86 | -3.1% | +32.9% | +33.1% | |
| Jul 15, 2025 | Gravier Pierre52 | Chief Financial Officer | Sell | 2,516 | $49.46 | $124,441.36 | -3.4% | +38.3% | +65.1% | |
| May 16, 2025 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 2,812 | $46.13 | $129,716.88 | -1.3% | +5.8% | +55.3% | |
| Apr 22, 2025 | Klein Matthew B.54 | Chief Executive Officer | Sell | 2,804 | $48.74 | $136,655.74 | -1.0% | -0.7% | - | |
| Apr 2, 2025 | Golden Lee Scott | EVP &Chief Medical Officer | Sell | 897 | $46.95 | $42,114.15 | -1.2% | +0.5% | +40.1% | |
| Mar 17, 2025 | Pauwels Eric62 | Chief Business Officer | Sell | 11,220 | $56.16 | $630,104.40 | -2.9% | -9.3% | +18.0% | |
| Mar 13, 2025 | Okey Stephanie56 | Director | Sell | 5,000 | $54.00 | $270,000.00 | -36.1% | -3.7% | +22.2% | |
| Mar 12, 2025 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 15,521 | $53.30 | $827,232.91 | -7.0% | -3.5% | +18.2% |